DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Roferon-A (Interferon Alfa-2A) - Blood Alkaline Phosphatase Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Blood Alkaline Phosphatase Increased (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Roferon-A (Interferon Alfa-2A) where reactions include blood alkaline phosphatase increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Roferon-A side effects in

Reported by a physician from United States on 2012-08-06

Patient:

Reactions: Weight Decreased, Blood Creatine Phosphokinase Increased, Pyrexia, Cardiac Disorder, Cerebral Haemorrhage, Dyspepsia, DRY Mouth, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, Stomatitis, Intracranial Tumour Haemorrhage, Anaemia, Aspartate Aminotransferase Increased, Neutropenia, Amylase Increased, Myalgia, Fatigue, Blood Uric Acid Increased, Myocardial Infarction, Thrombocytopenia, Decreased Appetite, Dyspnoea, Vomiting, Nausea, Lymphopenia, Alanine Aminotransferase Increased, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Hypophosphataemia, Diarrhoea, Respiratory Failure, Arthralgia, Neoplasm Malignant, Ejection Fraction Decreased, Hypothyroidism, Lipase Increased, Hypertension, Asthenia, Leukopenia, Influenza Like Illness

Adverse event resulted in: death

Drug(s) suspected as cause:
Roferon-A
    Dosage: given on nonconsecutive days, 3 mu at three times a week during the first week.
    Indication: Metastatic Renal Cell Carcinoma

Roferon-A
    Dosage: given 6 mu three times a week during second week.

Roferon-A
    Dosage: given 9 mu three times a week thereafter.



Possible Roferon-A side effects in male

Reported by a physician from France on 2012-08-01

Patient: male

Reactions: Blood Alkaline Phosphatase Increased, Hyperkalaemia, Anaemia, Lymphopenia, Bacterial Pyelonephritis, Hyponatraemia, Klebsiella Infection, Renal Failure, Gamma-Glutamyltransferase Increased, Cardiac Failure, Posterior Reversible Encephalopathy Syndrome, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Renal Cancer
    Start date: 2011-11-08
    End date: 2011-11-08

Roferon-A
    Indication: Renal Cancer
    Start date: 2011-10-24
    End date: 2011-11-21

Other drugs received by patient: Allopurinol; Candesartan Cilexetil; Previscan (France); Proscar; Temerit



Possible Roferon-A side effects in male

Reported by a physician from Germany on 2012-07-18

Patient: male, weighing 106.8 kg (235.0 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Pneumonia, Anaemia, Pneumonitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Roferon-A



Possible Roferon-A side effects in male

Reported by a physician from Germany on 2012-07-11

Patient: male, weighing 62.2 kg (136.8 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Hyperbilirubinaemia, Anaemia, Transaminases Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Roferon-A



Possible Roferon-A side effects in

Reported by a individual with unspecified qualification from Netherlands on 2012-03-21

Patient:

Reactions: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Calcium Metabolism Disorder, Hypersensitivity, Anaemia, Lymphopenia, Pulmonary Embolism, Hyponatraemia, Pyrexia, Blood Potassium Abnormal, Neoplasm Malignant, Gamma-Glutamyltransferase Increased, Neutropenia, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atrasentan
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma

Roferon-A
    Dosage: dose: 9 mu
    Indication: Metastatic Renal Cell Carcinoma

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017